TrademarkDir
THERANASE
DEAD

Serial Number

76327268

Owner

Antisoma Research Limited

Attorney

COLETTE A. DURST-BARKEY

Filing Date

Oct 19, 2001

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

THERANASE Trademark

Serial Number: 76327268 • Registration: 3072381

THERANASE is a trademark filed by Antisoma Research Limited on October 19, 2001. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Antisoma Research Limited (13 trademarks)

West Africa House
London England W5 3QR , GB

Entity Type: 03

Trademark Details

Filing Date

October 19, 2001

Registration Date

March 28, 2006

Published for Opposition

April 19, 2005

Cancellation Date

November 2, 2012

Goods & Services

Pharmaceutical preparations for use in the treatment of cancer

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 2, 2012 C8..
REGISTERED-PRINCIPAL REGISTER
Mar 28, 2006 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Feb 14, 2006 DP1B
NOTICE OF ALLOWANCE CANCELLED
Jan 3, 2006 IUCN
PAPER RECEIVED
Jan 3, 2006 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 12, 2005 NOAM
PUBLISHED FOR OPPOSITION
Apr 19, 2005 PUBO
NOTICE OF PUBLICATION
Mar 30, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 19, 2005 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 27, 2004 CNSA
ASSIGNED TO LIE
Sep 8, 2004 ALIE
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 2, 2004 RCSC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2004 CRFA
PAPER RECEIVED
Aug 12, 2004 MAIL
CASE FILE IN TICRS
May 21, 2004 CFIT
ASSIGNED TO EXAMINER
Mar 11, 2003 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2002 CRFA
PAPER RECEIVED
Nov 29, 2002 MAIL
LETTER OF SUSPENSION MAILED
Aug 26, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2002 CRFA
NON-FINAL ACTION MAILED
Jan 11, 2002 CNRT
ASSIGNED TO EXAMINER
Dec 28, 2001 DOCK

Related Trademarks

More from this Owner

ATTACK

ATTACK

ATTACK

ATTACK

ANTISOMA

ANTISOMA

ANTISOMA

ANTISOMA

ANTISOMA

ANTISOMA

MABINEX

MABINEX